semaglutide articles Weight loss with reduces pain, improves function in knee osteoarthritis Semaglutide and Cardiovascular Outcomes in

10.1038/s41586-021-03950-0 114 NiL.WuJ.LongY.TaoJ.XuJ.YuanX.et al (2019)

Neuropharmacology 112:399412

However, dizziness and lightheadedness occur in approximately 58% of semaglutide users, often related to rapid blood glucose changes, dehydration, or dosing adjustments rather than true vertigo

The Rise of Injectable Weight Loss Drugs Injectable weight loss drugs are making a big impact in obesity treatment

Gastrointestinal side effects tend to be worst early on or after a dose increase and frequently ease as your body adjusts over several weeks

if tablet-controlled, you may be eligible if stable and without complications Recent weight changes significant weight loss may affect eligibility temporarily Other medications taken alongside Wegovy Timing considerations are also important